Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

44.21
+1.082.50%
Post-market: 44.840.6300+1.43%19:43 EST
Volume:2.09M
Turnover:91.89M
Market Cap:11.85B
PE:18.60
High:44.44
Open:43.03
Low:42.96
Close:43.13
52wk High:49.62
52wk Low:31.90
Shares:268.11M
Float Shares:231.84M
Volume Ratio:0.71
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.38
EPS(LYR):1.80
ROE:30.56%
ROA:17.73%
PB:5.49
PE(LYR):24.60

Loading ...

Morgan Stanley Lifts Price Target on Exelixis to $45 From $44, Keeps Overweight Rating

MT Newswires Live
·
Nov 05

Barclays Keeps Their Hold Rating on Exelixis (EXEL)

TIPRANKS
·
Nov 05

U.S. RESEARCH ROUNDUP-ADM, Pinterest, UL Solutions

Reuters
·
Nov 05

Exelixis (EXEL): Is There More Value Left After Recent Growth?

Simply Wall St.
·
Nov 05

BRIEF-Exelixis Inc - Authorizes $750 Million Stock Repurchase By 2026 - SEC Filing

Reuters
·
Nov 05

Exelixis Announces $750 Million Stock Repurchase Program

TIPRANKS
·
Nov 05

Exelixis Q3 Non-GAAP Earnings, Revenue Increase

MT Newswires Live
·
Nov 05

Exelixis Inc - Authorizes $750 Mln Stock Repurchase by 2026 - SEC Filing

THOMSON REUTERS
·
Nov 05

Exelixis Reports Third Quarter Revenues of $597.8 Million

Reuters
·
Nov 05

Exelixis Q3 Adjusted EPS USD 0.78 VS. Ibes Estimate USD 0.61

THOMSON REUTERS
·
Nov 05

Exelixis Inc Outlook FY Net Product Revenues $2.10 Bln - $2.15 Bln

THOMSON REUTERS
·
Nov 05

Exelixis Outlook FY Revenue USD 2,300-2,350 Million

THOMSON REUTERS
·
Nov 05

Exelixis Shares Fall After Guggenheim Downgrade

MT Newswires Live
·
Nov 04

Truist Financial Sticks to Its Buy Rating for Exelixis (EXEL)

TIPRANKS
·
Nov 04

Exelixis Cut to Neutral From Buy by Guggenheim

Dow Jones
·
Nov 04

Guggenheim Downgrades Exelixis to Neutral From Buy

MT Newswires Live
·
Nov 03

Exelixis downgraded to Neutral from Buy at Guggenheim

TIPRANKS
·
Nov 03

Exelixis Inc expected to post earnings of 61 cents a share - Earnings Preview

Reuters
·
Nov 01

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Exelixis (EXEL)

TIPRANKS
·
Oct 31

Could Exelixis (EXEL) Pipeline Progress Signal a Turning Point for Revenue Diversification?

Simply Wall St.
·
Oct 29